Orthofix Medical Inc.

OFIX

US68752M1080

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 05/07/2024 BST			5-day change	1st Jan Change
13.51 ^USD	-0.07%		+1.89%	+0.22%

07-01	Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from Russell 2000 Defensive Index	CI
07-01	Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from Russell 2000 Value-Defensive Index	CI

Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from Russell 2000 Defensive Index

July 30, 2024

Latest news about Orthofix Medical Inc.

Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from Russell 2000 Defensive Index	06-30	CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from Russell 2000 Value-Defensive Index	06-30	CI
Orthofix Medical Names Michael Finegan as Board Chair	06-24	MT
Orthofix Medical Inc. Appoints Michael Finegan as Chair of Board of Directors	06-24	CI
Kimberley A. Elting Departs as President, Global Orthopedics of Orthofix Medical Inc	06-20	CI
Orthofix Medical Inc. Appoints Aviva Mcpherron as President of Global Operations and Quality	06-18	CI
Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer	06-11	CI
Orthofix Medical Inc. Appoints Max Reinhardt as President of Global Spine Business Effective June 10, 2024	05-23	CI
Orthofix Medical Inc. Announces FDA 510(K) Clearance for the Rodeo Telescopic Nail	05-09	CI
Roth MKM Upgrades Orthofix Medical to Buy From Neutral With $20 Price Target	05-08	MT
Transcript : Orthofix Medical Inc., Q1 2024 Earnings Call, May 07, 2024	05-07
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q1 Revenue $188.6M	05-07	MT
Orthofix Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Orthofix Medical Inc. Revises Earnings Guidance for the Year 2024	05-07	CI
Orthofix Medical Inc. Appoints Andres Cedron as New Chief Legal Officer	04-16	CI
Orthofix Medical Inc. Announces Board Resignation	04-12	CI
Orthofix Medical Inc. Appoints Lucas Vitale as Chief People and Business Operations Officer	03-18	CI
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set	03-05	MT
Orthofix Medical Inc. Provides Revenue Guidance for the First Quarter, Second Quarter and Third Quarter of 2024	03-05	CI
Transcript : Orthofix Medical Inc., Q4 2023 Earnings Call, Mar 05, 2024	03-05
Orthofix Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05	CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q4 Revenue $200.4M, vs. Street Est of $195.6M	03-05	MT
Orthofix Medical Guides For 2024 Sales of $785-$795 Million, vs CIQ Analyst Consensus of $799 Million	03-05	MT
Orthofix Medical Inc. Provides Earnings Guidance for the Year 2024	03-05	CI
Orthofix Medical Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-05	CI

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.

Sector

Medical Equipment, Supplies & Distribution

Calendar

06/08/2024 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Orthofix Medical Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

13.51 USD

Average target price

20.13 USD

Spread / Average Target

+49.03%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ORTHOFIX MEDICAL INC.	+0.22%	507M
ABBOTT LABORATORIES	-5.50%	181B
MEDTRONIC PLC	-5.79%	99.52B
BECTON, DICKINSON AND COMPANY	-6.59%	65.82B
DEXCOM, INC.	-8.38%	45.21B
CENCORA, INC.	+8.42%	43.85B
HOYA CORPORATION	+10.10%	42.17B
METTLER-TOLEDO INTERNATIONAL, INC.	+10.97%	28.75B
TERUMO CORPORATION	+18.89%	25.39B
WEST PHARMACEUTICAL SERVICES, INC.	-8.39%	23.5B

Other Medical Equipment, Supplies & Distribution